<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35757700</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.</ArticleTitle><Pagination><StartPage>886431</StartPage><MedlinePgn>886431</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">886431</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.886431</ELocationID><Abstract><AbstractText>Several COVID-19 convalescents suffer from the post-acute COVID-syndrome (PACS)/long COVID, with symptoms that include fatigue, dyspnea, pulmonary fibrosis, cognitive dysfunctions or even stroke. Given the scale of the worldwide infections, the long-term recovery and the integrative health-care in the nearest future, it is critical to understand the cellular and molecular mechanisms as well as possible predictors of the longitudinal post-COVID-19 responses in convalescent individuals. The immune system and T cell alterations are proposed as drivers of post-acute COVID syndrome. However, despite the number of studies on COVID-19, many of them addressed only the severe convalescents or the short-term responses. Here, we performed longitudinal studies of mild, moderate and severe COVID-19-convalescent patients, at two time points (3 and 6 months from the infection), to assess the dynamics of T cells immune landscape, integrated with patients-reported symptoms. We show that alterations among T cell subsets exhibit different, severity- and time-dependent dynamics, that in severe convalescents result in a polarization towards an exhausted/senescent state of CD4+ and CD8+ T cells and perturbances in CD4+ Tregs. In particular, CD8+ T cells exhibit a high proportion of CD57+ terminal effector cells, together with significant decrease of na&#xef;ve cell population, augmented granzyme B and IFN-&#x3b3; production and unresolved inflammation 6 months after infection. Mild convalescents showed increased na&#xef;ve, and decreased central memory and effector memory CD4+ Treg subsets. Patients from all severity groups can be predisposed to the long COVID symptoms, and fatigue and cognitive dysfunctions are not necessarily related to exhausted/senescent state and T cell dysfunctions, as well as unresolved inflammation that was found only in severe convalescents. In conclusion, the post-COVID-19 functional remodeling of T cells could be seen as a two-step process, leading to distinct convalescent immune states at 6 months after infection. Our data imply that attenuation of the functional polarization together with blocking granzyme B and IFN-&#x3b3; in CD8+ cells might influence post-COVID alterations in severe convalescents. However, either the search for long COVID predictors or any treatment to prevent PACS and further complications is mandatory in all patients with SARS-CoV-2 infection, and not only in those suffering from severe COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Wiech, Chroscicki, Swatler, Stepnik, De Biasi, Hampel, Brewinska-Olchowik, Maliszewska, Sklinda, Durlik, Wierzba, Cossarizza and Piwocka.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wiech</LastName><ForeName>Milena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chroscicki</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swatler</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stepnik</LastName><ForeName>Dawid</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Biasi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hampel</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery and Transplantology, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brewinska-Olchowik</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maliszewska</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery and Transplantology, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sklinda</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Radiology, Centre of Postgraduate Medical Education, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durlik</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery and Transplantology, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departament of Gastroenterological Surgery and Transplantology, Centre of Postgraduate Medical Education, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wierzba</LastName><ForeName>Waldemar</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Humanities and Economics, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cossarizza</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Cardiovascular Research, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piwocka</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="D053804">Granzymes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053804" MajorTopicYN="N">Granzymes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">T cell exhaustion/senescence</Keyword><Keyword MajorTopicYN="N">convalescents</Keyword><Keyword MajorTopicYN="N">full spectral cytometry</Keyword><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">inflammation resolution</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute COVID-syndrome (PACS)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>27</Day><Hour>4</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35757700</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. . A Novel Coronavirus From Patients With Pneumonia in China, 2019. N Engl J Med (2020) 382(8):727&#x2013;33. doi: 10.1056/NEJMoa2001017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-Month Consequences of COVID-19 in Patients Discharged From Hospital: A Cohort Study. Lancet Lond Engl (2021) 397(10270):220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The Four Most Urgent Questions About Long COVID. Nature (2021) 594(7862):168&#x2013;70. doi: 10.1038/d41586-021-01511-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01511-z</ArticleId><ArticleId IdType="pubmed">34108700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. . Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA (2020) 323(18):1843&#x2013;4. doi: 10.1001/jama.2020.3786</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3786</ArticleId><ArticleId IdType="pmc">PMC7066521</ArticleId><ArticleId IdType="pubmed">32159775</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. . Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019. J Clin Invest (2020) 130(5):2620&#x2013;9. doi: 10.1172/JCI137244</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua RL, Lukassen S, Trump S, Hennig BP, Wendisch D, Pott F, et al. . COVID-19 Severity Correlates With Airway Epithelium&#x2013;Immune Cell Interactions Identified by Single-Cell Analysis. Nat Biotechnol (2020) 38(8):970&#x2013;9. doi: 10.1038/s41587-020-0602-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0602-4</ArticleId><ArticleId IdType="pubmed">32591762</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med (2020) 382(13):1199&#x2013;207. doi: 10.1056/NEJMoa2001316</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA (2020) 323(13):1239. doi: 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen KW, Linderman SL, Moodie Z, Czartoski J, Lai L, Mantus G, et al. . Longitudinal Analysis Shows Durable and Broad Immune Memory After SARS-CoV-2 Infection With Persisting Antibody Responses and Memory B and T Cells. Cell Rep Med (2021) 2(7):100354. doi: 10.1016/j.xcrm.2021.100354</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100354</ArticleId><ArticleId IdType="pmc">PMC8253687</ArticleId><ArticleId IdType="pubmed">34250512</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth A, Chan PS, Jonas W. Addressing the Long COVID Crisis: Integrative Health and Long COVID. Glob Adv Health Med (2021) 10:216495612110565. doi: 10.1177/21649561211056597</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21649561211056597</ArticleId><ArticleId IdType="pmc">PMC8606968</ArticleId><ArticleId IdType="pubmed">34820152</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T, Perez-Potti A, Rivera-Ballesteros O, Str&#xe5;lin K, Gorin J-B, Olsson A, et al. . Robust T Cell Immunity in Convalescent Individuals With Asymptomatic or Mild COVID-19. Cell (2020) 183(1):158&#x2013;68.e14. doi: 10.1016/j.cell.2020.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7427556</ArticleId><ArticleId IdType="pubmed">32979941</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A, Kudryavtsev I, Starshinova A, Kudlay D, Zinchenko Y, Glushkova A, et al. . Post COVID-19 Syndrome in Patients With Asymptomatic/Mild Form. Pathog Basel Switz (2021) 10(11):1408. doi: 10.3390/pathogens10111408</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10111408</ArticleId><ArticleId IdType="pmc">PMC8620929</ArticleId><ArticleId IdType="pubmed">34832564</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and Predictors of Long COVID. Nat Med (2021) 27(4):626&#x2013;31. doi: 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Files JK, Boppana S, Perez MD, Sarkar S, Lowman KE, Qin K, et al. . Sustained Cellular Immune Dysregulation in Individuals Recovering From SARS-CoV-2 Infection. J Clin Invest (2021) 131(1):140491. doi: 10.1172/JCI140491</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140491</ArticleId><ArticleId IdType="pmc">PMC7773371</ArticleId><ArticleId IdType="pubmed">33119547</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J, Padilla S, Fern&#xe1;ndez-Gonz&#xe1;lez M, Garc&#xed;a JA, Agull&#xf3; V, Andreo M, et al. . Antibody Response to SARS-CoV-2 Is Associated With Long-Term Clinical Outcome in Patients With COVID-19: A Longitudinal Study. J Clin Immunol (2021) 41(7):1490&#x2013;501. doi: 10.1007/s10875-021-01083-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01083-7</ArticleId><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, et al. . Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses in Individuals Recovering From COVID-19 With and Without Post-Acute Symptoms. Cell Rep (2021) 36(6):109518. doi: 10.1016/j.celrep.2021.109518</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, et al. . Long-Term Perturbation of the Peripheral Immune System Months After SARS-CoV-2 Infection. BMC Med (2022) 20(1):26. doi: 10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell (2022) 185(5):881&#x2013;95.e20. doi: 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Sun L, Zhao Y, Feng D, Cheng J, Zhang G. Coronavirus Endoribonuclease Ensures Efficient Viral Replication and Prevents Protein Kinase R Activation. J Virol (2020) 95(7):e02103&#x2013;20. doi: 10.1128/JVI.02103-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02103-20</ArticleId><ArticleId IdType="pmc">PMC8092692</ArticleId><ArticleId IdType="pubmed">33361429</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S, Lo Tartaro D, Meschiari M, Gibellini L, Bellinazzi C, Borella R, et al. . Expansion of Plasmablasts and Loss of Memory B Cells in Peripheral Blood From COVID-19 Patients With Pneumonia. Eur J Immunol (2020) 50(9):1283&#x2013;94. doi: 10.1002/eji.202048838</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048838</ArticleId><ArticleId IdType="pubmed">32910469</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L, De Biasi S, Paolini A, Borella R, Boraldi F, Mattioli M, et al. . Altered Bioenergetics and Mitochondrial Dysfunction of Monocytes in Patients With COVID-19 Pneumonia. EMBO Mol Med (2020) 12(12):e13001. doi: 10.15252/emmm.202013001</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013001</ArticleId><ArticleId IdType="pmc">PMC7645870</ArticleId><ArticleId IdType="pubmed">33078545</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, et al. . Longitudinal Multi-Omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19. Immunity (2020) 53(6):1296&#x2013;1314.e9. doi: 10.1016/j.immuni.2020.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.11.017</ArticleId><ArticleId IdType="pmc">PMC7689306</ArticleId><ArticleId IdType="pubmed">33296687</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosa-Hern&#xe1;ndez VA, Torres-Ru&#xed;z J, Cervantes-D&#xed;az R, Romero-Ram&#xed;rez S, P&#xe1;ez-Franco JC, Meza-S&#xe1;nchez DE, et al. . B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients. Front Immunol (2020) 11:611004. doi: 10.3389/fimmu.2020.611004</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.611004</ArticleId><ArticleId IdType="pmc">PMC7744304</ArticleId><ArticleId IdType="pubmed">33343585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiecie&#x144; I, Rutkowska E, K&#x142;os K, Wi&#x119;sik-Szewczyk E, Jahnz-R&#xf3;&#x17c;yk K, Rzepecki P, et al. . Maturation of T and B Lymphocytes in the Assessment of the Immune Status in COVID-19 Patients. Cells (2020) 9(12):E2615. doi: 10.3390/cells9122615</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9122615</ArticleId><ArticleId IdType="pmc">PMC7762118</ArticleId><ArticleId IdType="pubmed">33291439</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S, Massri M, Grasse M, Fleischer V, Kellnerov&#xe1; S, Harpf V, et al. . Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 Infections. Viruses (2021) 13(12):2376. doi: 10.3390/v13122376</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122376</ArticleId><ArticleId IdType="pmc">PMC8707937</ArticleId><ArticleId IdType="pubmed">34960645</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S, Tartaro DL, Gibellini L, Paolini A, Quong A, Petes C, et al. . Endogenous Control of Inflammation Characterizes Pregnant Women With Asymptomatic or Paucisymptomatic SARS-CoV-2 Infection. Nat Commun (2021) 12(1):4677. doi: 10.21203/rs.3.rs-263619/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-263619/v1</ArticleId><ArticleId IdType="pmc">PMC8322155</ArticleId><ArticleId IdType="pubmed">34326336</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho T, Krammer F, Iwasaki A. The First 12 Months of COVID-19: A Timeline of Immunological Insights. Nat Rev Immunol (2021) 21(4):245&#x2013;56. doi: 10.1038/s41577-021-00522-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00522-1</ArticleId><ArticleId IdType="pmc">PMC7958099</ArticleId><ArticleId IdType="pubmed">33723416</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze JL, Aschenbrenner AC. COVID-19 and the Human Innate Immune System. Cell (2021) 184(7):1671&#x2013;92. doi: 10.1016/j.cell.2021.02.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.029</ArticleId><ArticleId IdType="pmc">PMC7885626</ArticleId><ArticleId IdType="pubmed">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A, Crotty S. Adaptive Immunity to SARS-CoV-2 and COVID-19. Cell (2021) 184(4):861&#x2013;80. doi: 10.1016/j.cell.2021.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau AWY, Turner VM, Bourne K, Hermes JR, Chan TD, Brink R. BAFFR Controls Early Memory B Cell Responses But Is Dispensable for Germinal Center Function. J Exp Med (2021) 218(2):e20191167. doi: 10.1084/jem.20191167</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191167</ArticleId><ArticleId IdType="pmc">PMC7604765</ArticleId><ArticleId IdType="pubmed">33119033</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A, Vasaikar SV, Lemos MP, Moodie Z, Lee Pebworth M-P, Henderson KE, et al. . Longitudinal Immune Dynamics of Mild COVID-19 Define Signatures of Recovery and Persistence. bioRxiv [Preprint] (2021) 05(26):442666. doi:&#xa0;10.1101/2021.05.26.442666</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.26.442666</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangaev A, Ketelaars SLC, Isaeva OI, Patiwael S, Dopler A, Hoefakker K, et al. . Identification and Characterization of a SARS-CoV-2 Specific CD8+ T Cell Response With Immunodominant Features. Nat Commun (2021) 12(1):2593. doi: 10.1038/s41467-021-22811-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22811-y</ArticleId><ArticleId IdType="pmc">PMC8110804</ArticleId><ArticleId IdType="pubmed">33972535</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. . Marked T Cell Activation, Senescence, Exhaustion and Skewing Towards TH17 in Patients With COVID-19 Pneumonia. Nat Commun (2020) 11(1):3434. doi: 10.21203/rs.3.rs-23957/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-23957/v1</ArticleId><ArticleId IdType="pmc">PMC7338513</ArticleId><ArticleId IdType="pubmed">32632085</ArticleId></ArticleIdList></Reference><Reference><Citation>Cossarizza A, Chang H, Radbruch A, Abrignani S, Addo R, Akdis M, et al. . Guidelines for the Use of Flow Cytometry and Cell Sorting in Immunological Studies (Third Edition). Eur J Immunol (2021) 51(12):2708&#x2013;3145. doi: 10.1002/eji.202170126</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202170126</ArticleId><ArticleId IdType="pmc">PMC11115438</ArticleId><ArticleId IdType="pubmed">34910301</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomiyama H, Matsuda T, Takiguchi M. Differentiation of Human CD8 + T Cells From a Memory to Memory/Effector Phenotype. J Immunol (2002) 168(11):5538&#x2013;50. doi: 10.4049/jimmunol.168.11.5538</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.11.5538</ArticleId><ArticleId IdType="pubmed">12023349</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcom EF, Nath A, Power C. Acute and Chronic Neurological Disorders in COVID-19: Potential Mechanisms of Disease. Brain J Neurol (2021) 144(12):3576&#x2013;88. doi: 10.1093/brain/awab302</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab302</ArticleId><ArticleId IdType="pmc">PMC8719840</ArticleId><ArticleId IdType="pubmed">34398188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. . Neurological Associations of COVID-19. Lancet Neurol (2020) 19(9):767&#x2013;83. doi: 10.1016/S1474-4422(20)30221-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee M-H, Wood J, et al. . Mild Respiratory SARS-CoV-2 Infection Can Cause Multi-Lineage Cellular Dysregulation and Myelin Loss in the Brain. BioRxiv Prepr Serv Biol (2022) 2022:01.07.475453. doi: 10.1101/2022.01.07.475453</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA (2020) 324(6):603&#x2013;5. doi: doi: 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan BN, Yoo HJ. Neurological Symptoms, Manifestations, and Complications Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 19 (COVID-19). J Neurol (2021) 268(9):3059&#x2013;71. doi: 10.1007/s00415-021-10406-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10406-y</ArticleId><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol (2021) 12:698169. doi: 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratzer B, Trapin D, Ettel P, K&#xf6;rm&#xf6;czi U, Rottal A, Tuppy F, et al. . Immunological Imprint of COVID-19 on Human Peripheral Blood Leukocyte Populations. Allergy (2021) 76(3):751&#x2013;65. doi: 10.1111/all.14647</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14647</ArticleId><ArticleId IdType="pmc">PMC7984452</ArticleId><ArticleId IdType="pubmed">33128792</ArticleId></ArticleIdList></Reference><Reference><Citation>Loretelli C, Abdelsalam A, D&#x2019;Addio F, Ben Nasr M, Assi E, Usuelli V, et al. . PD-1 Blockade Counteracts Post-COVID-19 Immune Abnormalities and Stimulates the Anti-SARS-CoV-2 Immune Response. JCI Insight (2021) 6(24):e146701. doi: 10.1172/jci.insight.146701</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.146701</ArticleId><ArticleId IdType="pmc">PMC8783674</ArticleId><ArticleId IdType="pubmed">34784300</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng N-P, Akbar AN, Goronzy J. CD28(-) T Cells: Their Role in the Age-Associated Decline of Immune Function. Trends Immunol (2009) 30(7):306&#x2013;12. doi: 10.1016/j.it.2009.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2009.03.013</ArticleId><ArticleId IdType="pmc">PMC2801888</ArticleId><ArticleId IdType="pubmed">19540809</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinti M, Appay V, Campisi J, Frasca D, F&#xfc;l&#xf6;p T, Sauce D, et al. . Aging of the Immune System: Focus on Inflammation and Vaccination. Eur J Immunol (2016) 46(10):2286&#x2013;301. doi: 10.1002/eji.201546178</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201546178</ArticleId><ArticleId IdType="pmc">PMC5156481</ArticleId><ArticleId IdType="pubmed">27595500</ArticleId></ArticleIdList></Reference><Reference><Citation>Strioga M, Pasukoniene V, Characiejus D. CD8+ CD28- and CD8+ CD57+ T Cells and Their Role in Health and Disease. Immunology (2011) 134(1):17&#x2013;32. doi: 10.1111/j.1365-2567.2011.03470.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2011.03470.x</ArticleId><ArticleId IdType="pmc">PMC3173691</ArticleId><ArticleId IdType="pubmed">21711350</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrati C, De Biasi S, Fidanza L, Gibellini L, Nasi M, Pinti M, et al. . The Importance of Advanced Cytometry in Defining New Immune Cell Types and Functions Relevant for the Immunopathogenesis of HIV Infection. AIDS Lond Engl (2020) 34(15):2169&#x2013;85. doi: 10.1097/QAD.0000000000002675</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000002675</ArticleId><ArticleId IdType="pubmed">32910071</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Guo W, Dong Y, Wang X, Dai D, Liu X, et al. . Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease. Front Immunol (2020) 11:580237. doi: 10.3389/fimmu.2020.580237</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.580237</ArticleId><ArticleId IdType="pmc">PMC7591707</ArticleId><ArticleId IdType="pubmed">33154753</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong F, Dai Y, Zheng T, Cheng L, Zhao D, Wang H, et al. . Peripheral CD4+ T Cell Subsets and Antibody Response in COVID-19 Convalescent Individuals. J Clin Invest (2020) 130(12):6588&#x2013;99. doi: 10.1172/JCI141054</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI141054</ArticleId><ArticleId IdType="pmc">PMC7685722</ArticleId><ArticleId IdType="pubmed">32841212</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n-Pe&#xf1;a S, Leon J, Chowdhary K, Michelson DA, Vijaykumar B, Yang L, et al. . Profound Treg Perturbations Correlate With COVID-19 Severity. Proc Natl Acad Sci USA (2021) 118(37):e2111315118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8449354</ArticleId><ArticleId IdType="pubmed">34433692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wang Z, Cao W, Wu Q, Yuan Y, Zhang X. Regulatory T Cells in COVID-19. Aging Dis (2021) 12(7):1545. doi: 10.14336/AD.2021.0709</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.0709</ArticleId><ArticleId IdType="pmc">PMC8460308</ArticleId><ArticleId IdType="pubmed">34631206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Mo L, Cai X, Wei L, Xie Z, Li H, et al. . ICOS Signal Facilitates Foxp3 Transcription to Favor Suppressive Function of Regulatory T Cells. Int J Med Sci (2018) 15(7):666&#x2013;73. doi: 10.7150/ijms.23940</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.23940</ArticleId><ArticleId IdType="pmc">PMC6001412</ArticleId><ArticleId IdType="pubmed">29910670</ArticleId></ArticleIdList></Reference><Reference><Citation>Martonik D, Parfieniuk-Kowerda A, Rogalska M, Flisiak R. The Role of Th17 Response in COVID-19. Cells (2021) 10(6):1550. doi: 10.3390/cells10061550</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061550</ArticleId><ArticleId IdType="pmc">PMC8235311</ArticleId><ArticleId IdType="pubmed">34205262</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of Inflammation: What Controls Its Onset? Front Immunol (2016) 7:160. doi: 10.3389/fimmu.2016.00160</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00160</ArticleId><ArticleId IdType="pmc">PMC4845539</ArticleId><ArticleId IdType="pubmed">27199985</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Gonz&#xe1;lez P, Tempio F, Fuentes C, Merino C, Vargas L, Simon V, et al. . Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements. Front Immunol (2021) 12:769059. doi: 10.3389/fimmu.2021.769059</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.769059</ArticleId><ArticleId IdType="pmc">PMC8567168</ArticleId><ArticleId IdType="pubmed">34745145</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsuyama Y, Yamakawa K, Kayano K, Maruyama M, Wada T, Fujimi S. Prolonged Enhancement of Cytotoxic T Lymphocytes in the Post-Recovery State of Severe COVID-19. J Intensive Care (2021) 9(1):76. doi: 10.1186/s40560-021-00591-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-021-00591-3</ArticleId><ArticleId IdType="pmc">PMC8685802</ArticleId><ArticleId IdType="pubmed">34930468</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological Dysfunction Persists for 8 Months Following Initial Mild-to-Moderate SARS-CoV-2 Infection. Nat Immunol (2022) 23(2):210&#x2013;6. doi: 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Novais FO, Nguyen BT, Scott P. Granzyme B Inhibition by Tofacitinib Blocks the Pathology Induced by CD8 T Cells in Cutaneous Leishmaniasis. J Invest Dermatol (2021) 141(3):575&#x2013;85. doi: 10.1016/j.jid.2020.07.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2020.07.011</ArticleId><ArticleId IdType="pmc">PMC7855313</ArticleId><ArticleId IdType="pubmed">32738245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiroyasu S, Zeglinski MR, Zhao H, Pawluk MA, Turner CT, Kasprick A, et al. . Granzyme B Inhibition Reduces Disease Severity in Autoimmune Blistering Diseases. Nat Commun (2021) 12(1):302. doi: 10.1038/s41467-020-20604-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20604-3</ArticleId><ArticleId IdType="pmc">PMC7804321</ArticleId><ArticleId IdType="pubmed">33436591</ArticleId></ArticleIdList></Reference><Reference><Citation>Perretti M, Leroy X, Bland EJ, Montero-Melendez T. Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation. Trends Pharmacol Sci (2015) 36(11):737&#x2013;55. doi: 10.1016/j.tips.2015.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2015.07.007</ArticleId><ArticleId IdType="pubmed">26478210</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A, Theodoridou M, Maltezou HC. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch Med Res (2021) 52(6):575&#x2013;81. doi: 10.1016/j.arcmed.2021.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou HC, Pavli A, Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (2021) 9(5):497. doi: 10.3390/vaccines9050497</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050497</ArticleId><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemi&#x144;ska I, W&#x119;glarczyk K, Surmiak M, Kurowska-Baran D, Sanak M, Siedlar M, et al. . Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions. Front Immunol (2021) 12:748097. doi: 10.3389/fimmu.2021.748097</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.748097</ArticleId><ArticleId IdType="pmc">PMC8511487</ArticleId><ArticleId IdType="pubmed">34659245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>